The original patent on insulin is expired. The current patents are on “improved” versions which is why the price is high - they are like any other new drug.
Yes, I understand that. Do you plan to sell the "old" version--one derived from cow pancreases, or will you manufacture a new version, one derived from recombinant DNA technology?
I'm just trying to understand your plan here, to corner the market.